Quick Answer
Oaktree Acquisition Corp. III Life Sciences reported Total Assets of $203.11 million for fiscal year 2025.
Oaktree Acquisition Corp. III Life Sciences Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $203.11M | +4.0% |
| 2024 | $195.25M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $201.25M | — | +1.0% |
| June 30, 2025 | $199.18M | — | +1.0% |
| March 31, 2025 | $197.24M | — | +1.0% |
| December 31, 2024 | $195.25M | — | — |
- Oaktree Acquisition Corp. III Life Sciences showed an increase of +4.0% in Total Assets compared to the prior fiscal year.
- Over the 2024–2025 period, Oaktree Acquisition Corp. III Life Sciences’s total assets has grown by 4.0% (from $195.25 million to $203.11 million).
- The most recent figure is from Oaktree Acquisition Corp. III Life Sciences’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: